1 BlackRock AstraZeneca PLC Trades
BlackRock acquired 2.23M AstraZeneca PLC shares worth $424M. That's 0.01% of their equity portfolio (1239th largest holding). The investor's estimated purchase price is $426M, resulting in a loss of 0.5%.
News about AstraZeneca PLC and BlackRock
AstraZeneca PLC $AZN Holdings Boosted by ABC Arbitrage SA
ABC Arbitrage SA grew its holdings in AstraZeneca PLC (NASDAQ: AZN) by 210.4% in the third quarter, according to its most recent Form 13F filing with the Sec...
AstraZeneca: Q4 Earnings Analysis - Ticks The Boxes, Upgrading To Buy
AstraZeneca PLC delivered robust 2025 results, with 9% product sales growth and a 23.4% operating margin, and raised its dividend. AZN targets $80bn in reven...
AstraZeneca PLC (AZN) Q4 2025 Earnings Call Transcript
AstraZeneca PLC (AZN) Q4 2025 Earnings Call Transcript
AZN Q4 Earnings Miss Estimates, Stock Up on Robust 2026 Growth Outlook
AZN misses Q4 EPS and sales estimates, but rallies after projecting mid-to-high single-digit revenue growth and low double-digit EPS growth for 2026.